The Mucin Paradox: Decoding the Molecular Strategies of Akkermansia muciniphila in Health and Disease

Akkermansia muciniphila is a next-generation probiotic linked to the intestinal barrier integrity and host metabolic well-being. However, its mucin utilization mechanisms remain uncharacterized. This review integrates genomic, biochemical, and metabolic data to show how A. muciniphila mucus-degrading enzymes (MDEs) degrade mucus, releasing nutrients that drive short-chain fatty acid production. It also highlights that A. muciniphila exhibits a dual nature: it safely stimulates regulated mucus degradation, improves barrier integrity, and feeds beneficial microbes. In contrast, dietary fiber shortages or metabolic stress trigger excessive degradation, compromising the gut barrier and increasing susceptibility to inflammation and pathogens. The probiotic effects of A. muciniphila against metabolic and inflammatory issues are driven by strictly regulated MDEs. Unlocking the safe therapeutic potential of this bacterium requires mapping out the spatial, temporal, and strain-specific details of these enzymes. Future research should combine multi-omics and host-interaction studies to clarify enzyme hierarchy, vesicle delivery, and context-dependent impacts.